GTBP (STOCKS)
GT Biopharma Inc. Common Stock
$0.460100
+0.013100 (+2.93%)
Prev close: $0.447000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Michael Breen
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $16.73M
- Employees
- 1
- P/E (TTM)
- -0.03
- P/B (TTM)
- 2.08
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Nonoperating Income/Loss | -$17.07M |
| Selling, General, and Administrative Expenses | $10.55M |
| Research and Development | $2.79M |
| Operating Income/Loss | -$13.34M |
| Income/Loss From Continuing Operations After Tax | -$30.41M |
| Income/Loss From Continuing Operations Before Tax | -$30.41M |
| Net Income/Loss | -$30.41M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$30.41M |
| Net Income/Loss Available To Common Stockholders, Basic | -$37.04M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $6.63M |
| Preferred Stock Dividends And Other Adjustments | $6.63M |
| Basic Earnings Per Share | -$7.77 |
| Diluted Earnings Per Share | -$7.77 |
| Basic Average Shares | 39,483,732 |
| Diluted Average Shares | 39,483,732 |
| Assets | $10.00M |
| Current Assets | $10.00M |
| Noncurrent Assets | $0.00 |
| Liabilities | $2.42M |
| Current Liabilities | $2.42M |
| Accounts Payable | $253.00K |
| Other Current Liabilities | $2.16M |
| Noncurrent Liabilities | $0.00 |
| Equity | $7.58M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $7.58M |
| Liabilities And Equity | $10.00M |
| Net Cash Flow From Operating Activities | -$13.18M |
| Net Cash Flow From Operating Activities, Continuing | -$13.18M |
| Net Cash Flow From Investing Activities | -$6.56M |
| Net Cash Flow From Investing Activities, Continuing | -$6.56M |
| Net Cash Flow From Financing Activities | $19.74M |
| Net Cash Flow From Financing Activities, Continuing | $19.74M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$30.41M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$30.41M |
| Other Comprehensive Income/Loss | $0.00 |